Due to its capability to promote the suppression of LH and sex-steroid hormones, this GnRH-ant has been employed in the treatment of hormone-dependent cancers such as prostate and ovarian cancer (Figure 2) (149). The gene discussed is GNRH1; the disease is ovarian cancer.